Freenome

Making early-stage cancer detection effective.

Updated May 20

Overview

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.

Stage

Series E

Latest Funding

$254M led by Roche

CEO

Headquarters

San Francisco

Company Size

501+

  • v0.3

  • Need something else? Drop us a line at hi@startups.gallery

  • startups.gallery is a handpicked gallery of the most promising early-stage companies. Crafted by Gonzalo and Louis.